Ranger Investment Management L.P. Invests $9.04 Million in Merit Medical Systems, Inc. $MMSI

Ranger Investment Management L.P. acquired a new position in Merit Medical Systems, Inc. (NASDAQ:MMSI) during the second quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 130,447 shares of the medical instruments supplier’s stock, valued at approximately $9,045,000.

Several other hedge funds have also recently bought and sold shares of the company. Kilter Group LLC acquired a new position in Merit Medical Systems during the 2nd quarter valued at about $25,000. Los Angeles Capital Management LLC acquired a new stake in shares of Merit Medical Systems in the fourth quarter valued at approximately $25,000. Torren Management LLC acquired a new stake in shares of Merit Medical Systems in the fourth quarter valued at approximately $38,000. Covestor Ltd raised its holdings in shares of Merit Medical Systems by 252.6% during the fourth quarter. Covestor Ltd now owns 469 shares of the medical instruments supplier’s stock valued at $41,000 after buying an additional 336 shares during the last quarter. Finally, Danske Bank A S bought a new stake in shares of Merit Medical Systems during the third quarter valued at approximately $42,000. 99.66% of the stock is currently owned by institutional investors.

Merit Medical Systems Stock Performance

Merit Medical Systems stock opened at $90.78 on Monday. Merit Medical Systems, Inc. has a 12-month low of $59.74 and a 12-month high of $94.75. The company has a debt-to-equity ratio of 0.44, a current ratio of 4.20 and a quick ratio of 2.79. The stock has a market capitalization of $5.42 billion, a PE ratio of 37.51, a price-to-earnings-growth ratio of 2.28 and a beta of 0.48. The firm has a 50 day simple moving average of $77.41 and a 200-day simple moving average of $72.51.

Merit Medical Systems (NASDAQ:MMSI) last announced its earnings results on Thursday, July 30th. The medical instruments supplier reported $1.19 EPS for the quarter, topping the consensus estimate of $0.96 by $0.23. The firm had revenue of $418.84 million for the quarter, compared to analysts’ expectations of $405.25 million. Merit Medical Systems had a return on equity of 13.75% and a net margin of 9.22%.The firm’s quarterly revenue was up 9.5% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.01 earnings per share. Merit Medical Systems has set its FY 2026 guidance at 4.250-4.350 EPS. As a group, equities research analysts expect that Merit Medical Systems, Inc. will post 3.81 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

MMSI has been the subject of a number of recent analyst reports. Robert W. Baird set a $98.00 price objective on Merit Medical Systems in a report on Friday, July 31st. Needham & Company LLC lifted their target price on Merit Medical Systems from $90.00 to $101.00 and gave the company a “buy” rating in a research note on Friday, July 31st. Bank of America boosted their price target on Merit Medical Systems from $92.00 to $97.00 and gave the stock a “neutral” rating in a research report on Thursday, August 13th. Wells Fargo & Company increased their price target on Merit Medical Systems from $74.00 to $83.00 and gave the stock an “equal weight” rating in a research note on Friday, July 31st. Finally, JPMorgan Chase & Co. raised their price target on Merit Medical Systems from $77.00 to $95.00 and gave the company an “overweight” rating in a report on Friday, July 31st. Eight analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $100.00.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.